BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20189378)

  • 1. Peritoneal pseudomyxoma arising from the urachus.
    Martínez A; Ferron G; Mery E; Gladieff L; Delord JP; Querleu D
    Surg Oncol; 2012 Mar; 21(1):1-5. PubMed ID: 20189378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urachal mucinous adenocarcinoma with pseudomyxoma peritonei: A case report.
    Liang L; Zhou N; Xu H; Liu D; Lu Y; Li F; Guo J
    Medicine (Baltimore); 2017 Sep; 96(35):e7548. PubMed ID: 28858081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucinous cystadenocarcinoma of the urachus associated with pseudomyxoma peritonei with emphasis on MR findings.
    Sugiyama K; Ito N
    Magn Reson Med Sci; 2009; 8(2):85-9. PubMed ID: 19571501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomyxoma Peritonei Arising From Urachal Mucinous Adenocarcinoma.
    Dimopoulos P; Kampantais S; Payne S; Liyanage S
    Urology; 2018 Jan; 111():e3-e4. PubMed ID: 29024737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging findings of urachal mucinous cystadenocarcinoma associated with pseudomyxoma peritonei.
    Takeuchi M; Matsuzaki K; Yoshida S; Nishitani H; Uehara H
    Acta Radiol; 2004 May; 45(3):348-50. PubMed ID: 15239434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic management of urachal mucinous borderline tumor associated with pseudomyxoma peritonei.
    Nozaki T; Yasuda K; Watanabe A; Fuse H
    Surg Laparosc Endosc Percutan Tech; 2011 Jun; 21(3):e152-5. PubMed ID: 21654292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
    In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudomyxoma peritonei, origin from appendix: report of cases with images.
    Lam CW; Kuo SJ; Chang HC; Chen ST; Chen YL; Yang LH; Hsieh CS
    Int Surg; 2003; 88(3):133-6. PubMed ID: 14584767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pseudomyxoma peritonei; a rare tumour that can be treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
    Smeenk RM; Verwaal VJ; Zoetmulder FA
    Ned Tijdschr Geneeskd; 2007 Feb; 151(7):418-23. PubMed ID: 17343142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus.
    Liu Y; Ishibashi H; Hirano M; Takeshita K; Mizumoto A; Ichinose M; Nishino E; Kashu I; Yamamoto Y; Sugarbaker PH; Yonemura Y
    Ann Surg Oncol; 2015 Aug; 22(8):2799-805. PubMed ID: 25572681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomyxoma Peritonei arising from a mucinous borderline ovarian tumour: Case report and literature review.
    Saluja M; Kenwright DN; Keating JP
    Aust N Z J Obstet Gynaecol; 2010 Aug; 50(4):399-403. PubMed ID: 20716272
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pseudomyxoma peritonei--a syndrome with varying prognosis].
    Mahteme H; Graf W
    Lakartidningen; 2003 Sep; 100(38):2936-40. PubMed ID: 14558213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomyxoma peritonei due to mucinous cystadenocarcinoma in situ of the urachus presenting as an inguinal hernia.
    Shinohara T; Misawa K; Sano H; Okawa Y; Takada A
    Int J Clin Oncol; 2006 Oct; 11(5):416-9. PubMed ID: 17058142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
    Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urachal mucinous cystadenocarcinoma with a cystic ovarian metastasis.
    Yanagisawa S; Fujinaga Y; Kadoya M
    AJR Am J Roentgenol; 2003 Apr; 180(4):1183-4. PubMed ID: 12646487
    [No Abstract]   [Full Text] [Related]  

  • 16. Intraperitoneal hyperthermia in the management of pseudomyxoma peritonei.
    Hsu KH; Chou CY; Chang YC
    Hepatogastroenterology; 2007; 54(73):47-52. PubMed ID: 17419229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomyxoma peritonei concomitant with early gastric cancer: report of a case.
    Ikejiri K; Anai H; Kitamura K; Yakabe S; Saku M; Yoshida K
    Surg Today; 1996; 26(11):923-5. PubMed ID: 8931226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pseudomyxoma peritonei--diagnosis and treatment].
    Kanemitsu Y; Kato T; Hirai T
    Gan To Kagaku Ryoho; 2003 May; 30(5):614-8. PubMed ID: 12795091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomyxoma Peritonei as a First Manifestation of KRAS-Mutated Urachal Mucinous Cystadenocarcinoma of the Bladder: A Case Report.
    Shelekhova KV; Zhuravlev AS; Krylova DD; Konstantinov AS; Shtan LV; Kheinshtein VA
    Int J Surg Pathol; 2017 Sep; 25(6):563-566. PubMed ID: 28449606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.